type here...

CATEGORIES

Medication

LATEST

1234Page 4 of 4

TRENDING

EDITORS CHOICE

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

How Suboxone Set Me Free From Opiate Addiction

Macarthur Medical Center -
A pregnant patient shares her journey to overcome opiate addiction to hydrocodone by starting Suboxone.

Beyond Stereotypes: The Exceptional Abilities That Make Autistic Minds Invaluable

Pat Farrell PhD -
According to The Lancet (in 2021), there were 61.8 million people on the autism spectrum in the world, which is equivalent to 1 out...

Blaming the Psychiatric Patient When It’s a Drug-Genetic Interaction

Medika Life -
How can patients with psychiatric or any other illnesses be viewed as non-compliant with their medical regimes when there is a persistent failure to investigate how their race and genetics are affecting treatment

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories